Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy
- PMID: 2877507
Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy
Abstract
Whether platelet microtubules are involved in clot retraction/contraction has been controversial. To address this question we have simultaneously measured two clotting parameters, clot structural rigidity and isometric contractile force, using a rheological technique. For recalcified PRP clots these two parameters began rising together at about 15 min after CaCl2 addition. In the concentration range affecting microtubule organization in platelets, colchicine, vinca alkaloids and taxol demonstrated insignificant effects on both clotting parameters of a recalcified PRP clot. For PRP clots induced by adding small amounts of exogenous thrombin, the kinetic curves of clot rigidity were biphasic and without a lag time. The first phase corresponded to a platelet-independent network forming process, while the second phase corresponded to a platelet-dependent process. These PRP clots began generating contractile force at the onset of the second phase. For both rigidity and force parameters, only the second phase of clotting kinetics was retarded by microtubule affecting reagents. When PRP samples were clotted by adding a mixture of CaCl2 and thrombin, the second phase clotting was accelerated and became superimposed on the first phase. The inhibitory effects of microtubule affecting reagents became less pronounced. Thrombin clotting of a two-component system (washed platelets/purified fibrinogen) was also biphasic, with the second phase being microtubule-dependent. In conclusion, platelet microtubules are important in PRP clotted with low concentrations of thrombin, during which fibrin network formation precedes platelet-fibrin interactions. On the other hand they are unimportant if a PRP clot is induced by recalcification, during which the fibrin network is constructed in the presence of platelet-fibrin interactions.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
The structural properties and contractile force of a clot.Cell Motil. 1982;2(5):445-55. doi: 10.1002/cm.970020504. Cell Motil. 1982. PMID: 6891618
-
Development of platelet contractile force as a research and clinical measure of platelet function.Cell Biochem Biophys. 2003;38(1):55-78. doi: 10.1385/CBB:38:1:55. Cell Biochem Biophys. 2003. PMID: 12663942 Review.
-
Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.Thromb Diath Haemorrh. 1974 Sep 30;32(1):216-31. Thromb Diath Haemorrh. 1974. PMID: 4454041
-
Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.Blood Coagul Fibrinolysis. 2008 Dec;19(8):765-70. doi: 10.1097/MBC.0b013e32830f1b68. Blood Coagul Fibrinolysis. 2008. PMID: 19002042
-
The contractile system of blood platelets and its function.Methods Achiev Exp Pathol. 1979;9:40-86. Methods Achiev Exp Pathol. 1979. PMID: 368520 Review.
Cited by
-
Humanin analogue, HNG, inhibits platelet activation and thrombus formation by stabilizing platelet microtubules.J Cell Mol Med. 2020 Apr;24(8):4773-4783. doi: 10.1111/jcmm.15151. Epub 2020 Mar 16. J Cell Mol Med. 2020. PMID: 32174022 Free PMC article.
-
Efficacy and Safety of Weekly Paclitaxel Therapy for Advanced Gastric Cancer Patients with Disseminated Intravascular Coagulation.J Gastrointest Cancer. 2015 Dec;46(4):438-41. doi: 10.1007/s12029-015-9744-x. J Gastrointest Cancer. 2015. PMID: 26142346 No abstract available.
-
Inner clot diffusion and permeation during fibrinolysis.Biophys J. 1993 Dec;65(6):2622-43. doi: 10.1016/S0006-3495(93)81314-6. Biophys J. 1993. PMID: 8312497 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials